<DOC>
	<DOCNO>NCT01154790</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability , pharmacokinetics 3 escalate load maintenance dose regimen CG100649 administer orally 7 total day healthy volunteer .</brief_summary>
	<brief_title>Phase I Study Multiple Oral Dosing CG100649</brief_title>
	<detailed_description>Data dictionary contains detailed description variable used registry , include source variable , cod information use CTCAE normal range relevant .</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<criteria>1 . 1955 year old . Body weight 50 kg ( male ) 45 kg ( female ) . Body weight must within 20 % ideal body weight height accord ideal body weight table . 2 . No significant congenital/chronic disease . No symptoms physical examination . 3 . Appropriate subject determine past medical history , laboratory test , serology urinalysis . 4 . Be able understand objective , method study , characteristic investigational drug , comply requirement study . Subject must provide write informed consent prior study participation . 1 . History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric cognitive disorder . 2 . History gastrointestinal disorder ( bleed , ulceration , hemorrhoid , pile ) disorder absorption , distribution , metabolism , excretion . 3 . History known hypersensitivity drug include CG100649 . 4 . After take rest sit position 3 minute , subject low blood pressure ( Systolic BP ≤ 90 mmHg Diastolic BP ≤ 50 mmHg ) high blood pressure ( Systolic BP ≥ 150 mmHg Diastolic BP ≥ 100 mmHg ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>healthy volunteer</keyword>
</DOC>